ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$11.68
-0.20 (-1.68%)
Open$11.93
Previous Close$11.88
Day High$11.98
Day Low$11.50
52W High$15.04
52W Low$7.16
Volume—
Avg Volume2.04M
Market Cap702.29M
P/E Ratio5.65
EPS$2.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-54.3% upside
Current
$11.68
$11.68
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 111.79M | 30.86M | 109.96M |
| Net Income | 87.40M | -124,101,933 | 24.47M |
| Profit Margin | 78.2% | -424.5% | 22.3% |
| EBITDA | -61,834,944 | -97,531,026 | 54.29M |
| Free Cash Flow | — | — | 22.49M |
| Rev Growth | +116.7% | -6.2% | -4.5% |
| Debt/Equity | 0.40 | 1.50 | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |